Promotion and what the label allows
Drug manufacturers are generally limited in how they promote a product for uses the FDA has not approved, and the line between promotion and the exchange of scientific information has been contested for years. Sales materials, social media posts, and remarks a representative makes in a doctor's office can all be scrutinized for what they claim. Medical affairs and commercial teams are usually kept on separate tracks partly for this reason. Answering an unsolicited question from a clinician is treated differently from raising an unapproved use on the company's own initiative. Clear internal rules about who answers which questions do much of the protective work.
Money that flows to prescribers
Payments to physicians for consulting, speaking, meals, or travel can raise concerns under the federal Anti-Kickback Statute when they are meant, even in part, to influence prescribing. Speaker programs in particular have drawn attention from the HHS Office of Inspector General. Manufacturers also report many transfers of value to physicians and certain other clinicians through the federal Open Payments program, which is public. Industry codes of conduct offer useful guidance, but they are voluntary and do not take the place of legal review. Fair market value, and a genuine business need for the service being paid for, are questions that come up again and again.
Reviewing the commercial program
A pharmaceutical compliance review usually starts with how the commercial team actually operates rather than how the policies describe it. We look at contracts with prescribers and speakers, how compensation was set, what materials were reviewed before use, and how adverse event reports picked up in the field are routed to the safety team. Patient support programs, including copay assistance and hub services, raise separate questions, especially where people covered by federal health programs are involved. If a problem appears, we discuss whether it calls for disclosure and how to fix it going forward. The goal is a set of practical rules a sales team can follow on an ordinary day.
